ScholarIQanswers from OpenAlex
Journal of Experimental & Clinical Cancer Research
JournalCitation impact & published research
Journal of Experimental & Clinical Cancer Research is a journal indexed in ScholarIQ from OpenAlex.
How many works does Journal of Experimental & Clinical Cancer Research have?
ScholarIQindexed works
Journal of Experimental & Clinical Cancer Research has 4,637 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Journal of Experimental & Clinical Cancer Research have?
ScholarIQcitation count
Journal of Experimental & Clinical Cancer Research has 245,154 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Journal of Experimental & Clinical Cancer Research?
ScholarIQh-index
Journal of Experimental & Clinical Cancer Research has an h-index of 185 in OpenAlex.
What is the article processing charge of Journal of Experimental & Clinical Cancer Research?
ScholarIQarticle processing charge
Journal of Experimental & Clinical Cancer Research lists an article processing charge of 3,490 USD in OpenAlex.
What is the OpenAlex record for Journal of Experimental & Clinical Cancer Research?
ScholarIQopenalex
The OpenAlex for Journal of Experimental & Clinical Cancer Research is on the source record.
What are the most-cited papers on Journal of Experimental & Clinical Cancer Research?
ScholarIQmost cited works
Health-related quality of life in breast cancer patients: A bibliographic review of the literature from 1974 to 2007
Ali Montazeri
Collagens and Cancer associated fibroblasts in the reactive stroma and its relation to Cancer biology
Neel I. Nissen, M.A. Karsdal, Nicholas Willumsen
ROS/PI3K/Akt and Wnt/β-catenin signalings activate HIF-1α-induced metabolic reprogramming to impart 5-fluorouracil resistance in colorectal cancer
Shuohui Dong, Shuo Liang, Zhiqiang Cheng, Xiang Zhang, Li Luo, Linchuan Li, Wenjie Zhang, Songhan Li, Qian Xu, Mingwei Zhong, Jiankang Zhu, Guangyong Zhang, Sanyuan Hu
Hepatocellular carcinoma-derived exosomal miRNA-21 contributes to tumor progression by converting hepatocyte stellate cells to cancer-associated fibroblasts
Yuan Zhou, Haozhen Ren, Bo Dai, Jun Li, Longcheng Shang, Jianfei Huang, Xiaolei Shi
circGFRA1 and GFRA1 act as ceRNAs in triple negative breast cancer by regulating miR-34a
Rongfang He, Peng Liu, Xiaoming Xie, Yujuan Zhou, Qianjin Liao, Wei Xiong, Xiaoling Li, Guiyuan Li, Zhaoyang Zeng, Hailin Tang